A Report of 2 Infant Siblings with Progressive Intrahepatic Familial Cholestasis Type 1 and a Novel Homozygous Mutation in the ATP8B1 Gene Treated with Partial External Biliary Diversion and Liver Transplant

Case series Patients: Male • Male / (siblings) Final Diagnosis: Progressive intrahepatic familial cholestasis type 1 (PFIC-1) Symptoms: Jaundice Medication: — Clinical Procedure: — Specialty: Transplantology Objective: Unusual clinical course Background: Current treatment options for progressive intrahepatic familial cholestasis type 1 (PFIC-1) comprise ursodeoxycholic acid (UDCA), partial external biliary diversion (PEBD), and liver transplantation (LTx). The role and timing of LTx in PFIC-1 remains debated. We present 2 case reports of male siblings with PFIC-1 who benefited from different treatments. Case Report: Both siblings harbored a homozygous truncating mutation in ATP8B1 characteristic for PFIC-1 and both underwent PEBD after unsuccessful UDCA treatment at the age of 7 and 5 months, respectively. The older brother, after initial improvement of symptoms, developed severe pruritus, cholestasis, and diarrhea 9 months after PEBD and underwent LTx at the age of 16 months. Chronic diarrhea and abnormal transaminases activity appeared soon after transplantation. A liver biopsy was performed 3 months after LTx and showed severe macrovesicular steatosis (95%). Sixteen months after LTx, total biliary diversion was performed, with rapid relief from diarrhea and significant regression of graft steatosis by <30%. In his brother we observed persistent severe pruritus and cholestasis after PEBD, but we decided to postpone LTx due to lack of a living related donor and risk of graft steatosis. Eight months after PEBD, bilirubin and bile acids significantly decreased and pruritus disappeared completely. Currently, in 5-year follow-up, liver function is stable and he has no pruritus. Conclusions: The good effect of PEBD may be delayed in PFIC-1, even in severe mutation; thus, the decision to perform LTx should be made cautiously. Total biliary diversion is an efficient procedure in case of persistent symptoms after LTx and can reverse graft steatosis in children with PFIC-1.

[1]  M. Rodriguez-Davalos,et al.  Biliary drainage as treatment for allograft steatosis following liver transplantation for PFIC‐1 disease: A single‐center experience , 2018, Pediatric transplantation.

[2]  Richard J. Thompson,et al.  Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies , 2018, Hepatology communications.

[3]  G. Mazariegos,et al.  Clinical Variability After Partial External Biliary Diversion in Familial Intrahepatic Cholestasis 1 Deficiency , 2017, Journal of pediatric gastroenterology and nutrition.

[4]  R. Superina,et al.  Outcomes following partial external biliary diversion in patients with progressive familial intrahepatic cholestasis. , 2017, Journal of pediatric surgery.

[5]  M. Kasahara,et al.  Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach , 2016, Pediatric transplantation.

[6]  J. Ryżko,et al.  Ileal Exclusion in Children With Progressive Familial Intrahepatic Cholestasis , 2014, Journal of pediatric gastroenterology and nutrition.

[7]  E. Sokal,et al.  Recovery of graft steatosis and protein‐losing enteropathy after biliary diversion in a PFIC 1 liver transplanted child , 2012, Pediatric transplantation.

[8]  Richard J. Thompson,et al.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies. , 2010, Journal of hepatology.

[9]  B. Stieger,et al.  ATP8B1 and ABCB11 analysis in 62 children with normal gamma‐glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history , 2010, Hepatology.

[10]  S. Uemoto,et al.  Liver retransplantation with external biliary diversion for progressive familial intrahepatic cholestasis type 1: A case report , 2009, Pediatric transplantation.

[11]  T. Manabe,et al.  Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  B. Shneider Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy , 2004, Pediatric transplantation.

[13]  Richard J. Thompson,et al.  Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. , 2004, Gastroenterology.

[14]  T. Drewniak,et al.  Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass. , 2003, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[15]  L. Klomp,et al.  Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. , 2003, Journal of hepatology.

[16]  M. Hasegawa,et al.  Intractable diarrhea after liver transplantation for Byler's disease: Successful treatment with bile adsorptive resin , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  L. Frulloni,et al.  Progressive familial intrahepatic cholestasis. , 2002, Acta bio-medica : Atenei Parmensis.

[18]  N. Freimer,et al.  A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis , 1998, Nature Genetics.

[19]  P. Whitington,et al.  Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. , 1988, Gastroenterology.